Amudhan Murugesan
Overview
Explore the profile of Amudhan Murugesan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Selvavinayagam S, Sankar S, Yong Y, Anshad A, Chandramathi S, Somasundaram A, et al.
PLOS Glob Public Health
. 2024 Dec;
4(12):e0004157.
PMID: 39739977
[This corrects the article DOI: 10.1371/journal.pgph.0003608.].
2.
Selvavinayagam S, Sankar S, Yong Y, Anshad A, Chandramathi S, Somasundaram A, et al.
PLOS Glob Public Health
. 2024 Nov;
4(11):e0003608.
PMID: 39570962
The decline in dengue incidence and/or prevalence during the COVID-19 pandemic (2020-22) appears to be attributed to reduced treatment-seeking rates, under-reporting, misdiagnosis, disrupted health services and reduced exposure to mosquito...
3.
Selvavinayagam S, Sankar S, Yong Y, Murugesan A, Suvaithenamudhan S, Hemashree K, et al.
Sci Rep
. 2024 Jul;
14(1):17476.
PMID: 39080396
In December 2023, we observed a notable shift in the COVID-19 landscape, when JN.1 omicron emerged as the predominant SARS-CoV-2 variant with a 95% incidence. We characterized the clinical profile,...
4.
Ramalingam G, Muthukumar A, Sivadoss R, Rajan G, Aridass D, Murugesan A, et al.
J Family Med Prim Care
. 2024 Jul;
13(5):1727-1733.
PMID: 38948575
Introduction: The coronavirus disease 2019 (COVID-19) is a viral infection characterized by respiratory and gastrointestinal symptoms. The causative agent of this infection is the severe acute respiratory syndrome coronavirus 2...
5.
Selvavinayagam S, Sankar S, Yong Y, Anshad A, Chandramathi S, Somasundaram A, et al.
medRxiv
. 2024 Jun;
PMID: 38883728
Background: Dengue is a vector-borne viral disease impacting millions across the globe. Nevertheless, akin to many other diseases, reports indicated a decline in dengue incidence and seroprevalence during the COVID-19...
6.
Vimali J, Yong Y, Murugesan A, Govindaraj S, Raju S, Balakrishnan P, et al.
Viral Immunol
. 2024 May;
37(5):240-250.
PMID: 38808464
Human pegivirus (HPgV) appears to alter the prognosis of HIV disease by modulating T cell homeostasis, chemokine/cytokine production, and T cell activation. In this study, we evaluated if HPgV had...
7.
Selvavinayagam S, Sankar S, Yong Y, Murugesan A, Suvaithenamudhan S, Hemashree K, et al.
medRxiv
. 2024 May;
PMID: 38699322
In December 2023, we observed a notable shift in the COVID-19 landscape, when the JN.1 emerged as a predominant SARS-CoV-2 variant with a 95% incidence. We characterized the clinical profile,...
8.
Vimali J, Yong Y, Murugesan A, Tan H, Zhang Y, Ashwin R, et al.
Front Biosci (Landmark Ed)
. 2024 Mar;
29(3):128.
PMID: 38538288
Background: Chronic viral infection results in impaired immune responses rendering viral persistence. Here, we compared the quality of T-cell responses among chronic hepatitis B virus (HBV), hepatitis C virus (HCV)...
9.
Selvavinayagam S, Suvaithenamudhan S, Yong Y, Hemashree K, Rajeshkumar M, Kumaresan A, et al.
J Med Virol
. 2024 Feb;
96(2):e29456.
PMID: 38329187
A state-wide prospective longitudinal investigation of the genomic surveillance of the omicron B.1.1.529 SARS-CoV-2 variant and its sublineages in Tamil Nadu, India, was conducted between December 2021 and March 2023....
10.
Selvavinayagam S, Karishma S, Hemashree K, Yong Y, Suvaithenamudhan S, Rajeshkumar M, et al.
Lancet Reg Health Southeast Asia
. 2023 Dec;
19:100272.
PMID: 38076717
Background: Despite the continued vaccination efforts, there had been a surge in breakthrough infections, and the emergence of the B.1.1.529 omicron variant of SARS-CoV-2 in India. There is a paucity...